GlassScriptPhysician profile
Susan M Dausch
NPI 1891787305
$2,966.79
in general payments reported to CMS, 2019-2025
34 companies · $496 in 2025
The $496 reported for 2025 was more than what 79% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $104 · 2021: $563 · 2022: $722 · 2023: $497 · 2024: $346 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.59 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $865.51 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $247.05 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $183.09 | 2021-2022 | |
| Organon LLC | $143.47 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $126.07 | 2021-2024 | Acessa Provu System, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Biogen, INC. | $123.83 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $118.01 | 2019-2025 | Paragard T 380a, Insorb |
| Pfizer INC. | $117.45 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.97 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $82.23 | 2019-2024 | Gardasil, Gardasil 9 |
| Sumitomo Pharma America, INC. | $78.49 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $76.76 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $67.10 | 2021-2022 | |
| Exeltis, USA INC. | $62.62 | 2022-2024 | Slynd |
| Scynexis, INC. | $61.28 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $58.11 | 2021 | |
| Aspira Women'S Health INC | $48.02 | 2022-2023 | Ova1 |
| Therapeuticsmd, INC. | $46.51 | 2019-2021 | |
| Minerva Surgical, INC | $45.57 | 2021-2022 | |
| Shield Therapeutics INC | $45.52 | 2022-2023 | Accrufer |
| Daiichi Sankyo INC. | $26.42 | 2025 | Injectafer |
| Mycovia Pharmaceuticals, INC. | $25.86 | 2022-2023 | Vivjoa |
| Lupin INC. | $25.06 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $24.61 | 2019 | |
| Allergan, INC. | $23.62 | 2019 | |
| Millicent US INC | $22.34 | 2024 | Intrarosa, Femring |
| Medicem INC. | $22.31 | 2021 | |
| Novo Nordisk INC | $17.91 | 2023 | |
| Amag Pharmaceuticals, INC. | $15.16 | 2019 | |
| Amgen INC. | $14.16 | 2025 | Evenity |
| Renovia INC | $13.72 | 2021 | |
| Evofem Biosciences, INC. | $13.51 | 2020 | |
| Covidien LP | $12.48 | 2019 | |
| Ethicon US, LLC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Dausch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.